These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35298286)

  • 21. Topical interferon alpha-2B topic as the first therapeutic option in a clinical case of conjunctival intraepithelial neoplasia.
    Pagán Carrasco S; Arranz Maestro D
    Arch Soc Esp Oftalmol; 2017 Sep; 92(9):442-446. PubMed ID: 28292536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
    Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE
    Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b.
    Rocha-de-Lossada C; Alba-Linero C; Borroni D; Rachwani-Anil R; Zamorano-Martín F; Rodríguez-Calvo-de-Mora M
    Rom J Ophthalmol; 2020; 64(1):62-65. PubMed ID: 32292860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adjuvant topical interferon-alpha-2b treatment in epithelial tumors of the ocular surface].
    Fuchsluger TA; Hintschich C; Steuhl KP; Meller D
    Ophthalmologe; 2006 Feb; 103(2):124-8. PubMed ID: 16047150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Ocular Surface Squamous Neoplasia with Topical and Intralesional Interferon Alpha 2B in Mexicans.
    Nava-Castañeda Á; Hernández-Orgaz J; Garnica-Hayashi L; Ansart A; Matus G; Tovilla-Canales JL
    Nepal J Ophthalmol; 2018 Jul; 10(20):143-150. PubMed ID: 31056557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pegylated Interferon Alpha 2a for the Treatment of Ocular Surface Squamous Neoplasia.
    Park J; Han J; Chung TY; Lim DH; Choi CY
    Cornea; 2022 Oct; 41(10):1271-1275. PubMed ID: 36107845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy, safety and cost-effectiveness of 5-fluorouracil versus interferon α-2b as adjuvant therapy after surgery in ocular surface squamous neoplasia in a southern European tertiary hospital.
    San Román Llorens JJ; Fernández-Gurria M; Artaechevarria Artieda J; Alejandre Alba N; García Sandoval B; Jiménez-Alfaro Morote I
    Int Ophthalmol; 2024 Apr; 44(1):184. PubMed ID: 38630143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up of conjunctival melanoma treated with topical interferon alpha-2b eye drops as adjunctive therapy following surgical resection.
    Kikuchi I; Kase S; Ishijima K; Ishida S
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2271-2276. PubMed ID: 28752368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes.
    Bakal K; Molugu S; Machakuri K; Bejjanki KM; Kapoor AG; Kaliki S
    Int Ophthalmol; 2024 Jun; 44(1):251. PubMed ID: 38907750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response.
    Kaliki S; Bejjanki KM; Desai A; Mohamed A
    Semin Ophthalmol; 2019; 34(7-8):465-472. PubMed ID: 31370766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment.
    Leventer I; Singh H; Pashaee B; Raimondo CD; Khakh CK; Martin JL; Acharya B; Zhang Q; Lally SE; Shields CL
    Asia Pac J Ophthalmol (Phila); 2024; 13(2):100052. PubMed ID: 38521390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Two cases of conjunctival malignant melanoma treated with topical interferon alpha-2b drop as an adjuvant therapy].
    Kase S; Ishijima K; Noda M; Ishida S
    Nippon Ganka Gakkai Zasshi; 2011 Nov; 115(11):1043-7. PubMed ID: 22171510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C.
    Nemet AY; Sharma V; Benger R
    Clin Exp Ophthalmol; 2006; 34(4):375-7. PubMed ID: 16764660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
    Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
    Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical interferon alpha-2b as an adjunctive therapy in recurrent conjunctival papilloma.
    Muralidhar R; Sudan R; Bajaj MS; Sharma V
    Int Ophthalmol; 2009 Feb; 29(1):61-2. PubMed ID: 18000647
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessing Profile and Treatment Outcome in Patients of Ocular Surface Squamous Neoplasia (OSSN).
    Shrestha E; Banstola L; Man I; Gurung B; Gurung H; Adhikari HB
    Nepal J Ophthalmol; 2019 Jul; 11(22):181-188. PubMed ID: 32792695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Pegylated Interferon and Mitomycin C on Ocular Surface Squamous Neoplasia in Xeroderma Pigmentosum: A Case Series.
    Dirar QS; Musalem HM; Al-Hazzaa SAF; Al Zoba AA; Almalki AA
    Am J Case Rep; 2020 Apr; 21():e921301. PubMed ID: 32251268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study.
    Galor A; Karp CL; Chhabra S; Barnes S; Alfonso EC
    Br J Ophthalmol; 2010 May; 94(5):551-4. PubMed ID: 19493859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical pharmacotherapy for ocular surface squamous neoplasia: systematic review and meta-analysis.
    Kozma K; Dömötör ZR; Csutak A; Szabó L; Hegyi P; Erőss B; Helyes Z; Molnár Z; Dembrovszky F; Szalai E
    Sci Rep; 2022 Aug; 12(1):14221. PubMed ID: 35987957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.